Aquestive Therapeutics Quarterly Balance Sheet
NASDAQ: AQSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Aquestive Therapeutics financial position
As of Jun 30, 2026, Aquestive Therapeutics reported total assets of $132.1 million, up 41.0% from a year earlier against total liabilities of $188.7 million. Shareholders' equity was negative at -$56.6 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $98.5 million in cash and equivalents against $50.7 million of debt, a net cash position of $47.8 million.
The current ratio (current assets divided by current liabilities) was 7.19, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Aquestive Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 98.49M | 110.73M | 121.17M | 129.06M | 60.54M | 68.66M | 71.55M | 77.89M | 89.87M | 95.20M | 23.87M | 24.92M |
| Receivables | 9.33M | 6.87M | 17.76M | — | — | — | 7.34M | — | — | — | 8.47M | — |
| Inventory | 7.37M | 8.07M | 6.17M | 7.88M | 8.13M | 7.20M | 6.04M | 7.02M | 6.97M | 7.73M | 6.77M | 7.08M |
| Total Current Assets | 118.49M | 130.18M | 149.27M | 151.67M | 81.72M | 89.17M | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M | 42.46M |
| Property, Plant & Equipment | 3.96M | 3.84M | 3.89M | 3.92M | 3.86M | 3.80M | 3.80M | 3.85M | 3.92M | 4.05M | 4.18M | 4.55M |
| Intangible Assets | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.24M | 1.28M | 1.32M |
| Total Assets | 132.10M | 141.13M | 160.43M | 163.56M | 93.70M | 102.23M | 101.42M | 109.96M | 117.61M | 129.52M | 57.42M | 59.45M |
| Accounts Payable | 8.96M | 11.89M | 29.86M | 10.87M | 11.95M | 12.28M | 10.29M | 7.57M | 5.70M | 10.52M | 8.93M | 9.99M |
| Short-Term Debt | 32.00K | — | 9.99M | — | — | — | — | — | — | — | — | — |
| Total Current Liabilities | 16.48M | 31.75M | 47.61M | 25.57M | 23.16M | 18.30M | 18.86M | 15.15M | 13.89M | 18.06M | 18.31M | 24.06M |
| Long-Term Debt | 50.65M | 25.10M | 27.52M | 45.00M | 45.00M | 45.00M | 32.50M | 45.00M | 45.00M | 45.00M | 27.51M | 38.98M |
| Total Liabilities | 188.69M | 175.18M | 194.09M | 167.67M | 166.29M | 163.16M | 161.58M | 155.38M | 153.08M | 165.82M | 163.91M | 162.38M |
| Shareholders' Equity | -56.59M | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.30M | -106.49M | -102.93M |
| Retained Earnings | -477.92M | -455.06M | -447.00M | -415.14M | -399.69M | -386.14M | -363.21M | -346.16M | -334.65M | -331.90M | -319.08M | -310.97M |
| Total Debt | 50.69M | 25.10M | 37.51M | 45.00M | 45.00M | 45.00M | 32.50M | 45.00M | 45.00M | 45.00M | 27.51M | 38.98M |
| Net Cash (Debt) | 47.80M | 85.64M | 83.66M | 84.06M | 15.54M | 23.66M | 39.05M | 32.89M | 44.87M | 50.20M | -3.64M | -14.06M |
| Shares Outstanding | 125.51M | 124.28M | 122.04M | 121.66M | 99.35M | 99.32M | 91.41M | 91.18M | 91.06M | 90.48M | 68.53M | 66.74M |
This table shows 12 quarterly periods of Aquestive Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow AQST's reporting calendar. What is a balance sheet?